- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Salix Pharmaceuticals Ltd+ Add to Watchlist
SLXP:US85.1750 USD 0.1350 0.16%
As of 13:00:40 ET on 12/19/2013.
Company Profile for Salix Pharmaceuticals Ltd (SLXP)
Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.
Salix Pharmaceuticals Ltd
Key Executives for Salix Pharmaceuticals Ltd (SLXP)
|Carolyn J LoganPresident/CEO||Adam C DerbyshireExec VP:Finance & Admin/CFO|
|William P ForbesExec VP:Research & Development||Rick D ScruggsExec VP:Business Development|